Skip to content
Jul 11 2017

Einstein Choice: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Clinical Question

In patients who would benefit from continued anti-coagulation is treatment dose rivaroxaban vs thromboprophylactic dose as effective as aspirin for prevention of recurrent thromboembolism?

Bottom Line

Rivaroxaban at both treatment dose (20mg) and a thromboprophylactic dose (10mg), was more effective than aspirin for prevention of recurrent VTE among pt who were in equipoise for continued anticoagulation with similar risk of bleeding.

Presentation

No Url Found
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.